How a medical catastrophe became a vital tool in modern medicine

The Return of Thalidomide · 6:18 · Video: SciShow · Watch at the source

In short: Thalidomide is synonymous with one of the most devastating drug safety failures in history. Yet, decades after its reputation was destroyed by life-altering fetal abnormalities, researchers are finding that this dangerous substance still holds significant therapeutic value. How can a drug so harmful remain worth using?

The legacy of thalidomide is defined by a global tragedy. During the mid-20th century, the drug was administered in clinical trials by the pharmaceutical company Richardson-Merrell. Despite the drug being blocked from the American market, thousands of pregnant people still ingested it, leading to many babies being born with shortened limbs and other serious medical conditions, as well as instances of miscarriages and stillbirths.

A pivotal figure in this history was FDA medical examiner Frances Oldham Kelsey. She is credited with stalling the new drug application for thalidomide in the United States, preventing the widespread distribution that occurred in other regions. Her cautious approach saved countless lives, though it could not prevent the harm caused by those who had already participated in the company's trials.

Today, the conversation around thalidomide has shifted from pure catastrophe to a complex medical nuance. While the risks of fetal abnormalities remain a central concern, recent research suggests the drug still has a place in modern medicine. This creates a difficult tension between its capacity to cause life-altering damage and its potential to treat specific conditions.

The impact of the scandal continues to resonate. As recently as September 2024, survivors and their families traveled to Washington, D.C., to lobby the government for continued support. The history of thalidomide serves as a profound lesson in drug regulation and the enduring necessity of rigorous safety standards in pharmaceutical development.

Opens the Intellect+ feed with this card first. Swipe up for the next one.

Sources

To cite this card, link to https://intellectplus.co.uk/app/science-the-return-of-thalidomide.

How we source, check and correct cards: Editorial standards.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

Finding something worth knowing…